Glucotrack, Inc. Operating Income Loss

• Glucotrack, Inc. showed a decrease of -10.6% in Operating Income Loss from 2024 to 2025.
• This data is from Glucotrack, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), Glucotrack, Inc.'s Operating Income Loss has declined by 1,274.9%.
• Historical annual values: Fiscal year 2025: -$16.09 million | Fiscal year 2024: -$14.55 million | Fiscal year 2023: -$7.10 million | Fiscal year 2022: -$4.43 million | Fiscal year 2021: -$4.04 million | Fiscal year 2020: -$3.13 million | Fiscal year 2019: $3.51 million | Fiscal year 2018: -$6.54 million | Fiscal year 2017: $10.58 million | Fiscal year 2016: -$5.66 million | Fiscal year 2015: -$4.66 million | Fiscal year 2014: -$3.61 million | Fiscal year 2013: -$3.03 million | Fiscal year 2012: -$2.77 million | Fiscal year 2011: -$2.33 million | Fiscal year 2010: -$1.39 million | Fiscal year 2009: -$1.17 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026